Cardiac resynchronization therapy device
Mixed ischaemic and non-ischaemic cardiomyopathy
Loading Stack -
0 images remaining
Cardiac resynchronization therapy (CRT) device in situ (right atrial, right ventricular and coronary sinus leads). An insulated right ventricular lead indicates that this is a CRT defibrillator device. The cardiac silhouette is enlarged. There is no confluent consolidation.
Cardiac resynchronization therapy (CRT) is indicated in patients with heart failure (moderate to severe), systolic dysfunction (left ventricular ejection fraction <35%) and prolonged QRS duration despite being treated with appropriate pharmacotherapy. CRT works through simultaneous pacing of the right and left ventricles. The goal of CRT is to improve the patient's left ventricular dyssynchrony which is largely secondary to a left bundle branch block. CRT devices may also have defibrillator capacity 1-2.
- 1. Christophe Leclercq, Joshua M. Hare. Ventricular Resynchronization. Circulation. 109 (3): 296. doi:10.1161/01.CIR.0000113458.76455.03 - Pubmed
- 2. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. The New England journal of medicine. 350 (21): 2140-50. doi:10.1056/NEJMoa032423 - Pubmed